Search Within

Richard Jirui Lin

  1. "Immunology Program Faculty"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (4)
  3. Review (1)
Groups
  1. Center for Hematologic Malignancies (13)
  2. Department of Medicine (13)
  3. GSK Faculty (13)
  4. Hematologic Malignancies, Division of (13)
  5. Immunology Program Faculty (13)
  6. Sloan Kettering Institute Faculty (13)

More Groups

People
  1. Marcel Van Den Brink (12)
  2. Miguel-Angel Perales (12)
  3. Gunjan Shah (11)
  4. Michael Scordo (11)
  5. Sergio Giralt (11)
  6. Boglarka Gyurkocza (8)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (4)
  4. 2021 (2)
  5. 2020 (4)
  6. 2019 (1)
Publications
  1. Blood (4)
  2. Biology of Blood and Marrow Transplantation (2)
  3. Bone Marrow Transplantation (2)
  4. Blood Advances (1)
  5. Frontiers in Immunology (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (5)
  2. Elsevier Inc. (3)
  3. Nature Publishing Group (2)
  4. American Society of Clinical Oncology (1)
  5. Frontiers Media S.A. (1)
  6. Massachusetts Medical Society (1)

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of broad-spectrum antibiotic exposure on CAR-T therapy outcomes in B-cell lymphoma: A multicenter international study
    Meeting Abstract

    Shouval, R.; Fei, T.; Gabrielli, G.; Smith, N. G.; Ghilardi, G.; Slingerland, J.; Peled, J. U.; Taur, Y.; Nasta, S. D.; Luna, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A reproducible inflammatory biomarker signature identifies non-Hodgkin lymphoma patients at high risk of CAR-T treatment failure across different cohorts
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fei, T.; Fein, J.; Tomas, A. A.; De LaPuerta, M. C.; Dahi, P.; Danylesko, I.; Epstein-Peterson, Z.; Fried, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Tracking immune reconstitution in the bone marrow following allogeneic hematopoietic transplantation in humans reveals early dominance of innate lymphoid populations
    Meeting Abstract

    DeWolf, S.; Kuttiyara, J.; Vinci, P.; Slingerland, J.; Marcello, L. T.; Giardina, P. A.; Donohoe, W.; Lin, R. J.; Papadopoulos, E. B.; Gyurkocza, B.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Inflammatory biomarker clusters are predictive of response and toxicity in large B-cell lymphoma treated with CD19 CAR-T cell therapy
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fein, J. A.; Tomas, A. A.; Batlevi, C. L.; De Lapuerta, M. C.; Dahi, P. B.; Danylesko, I.; Fried, S.; Funnell, T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • The Simplified Comorbidity Index: A new tool for prediction of nonrelapse mortality in allo-HCT
    Journal Article

    Shouval, R.; Fein, J. A.; Cho, C.; Avecilla, S. T.; Ruiz, J.; Alarcon Tomas, A.; Sanchez-Escamilla, M.; Castillo Flores, N.; Yáñez, L.; Barker, J. N.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Impact of TP53 genomic alterations in large B-cell lymphoma treated with CD19-chimeric antigen receptor T-cell therapy
    Journal Article

    Shouval, R.; Alarcon Tomas, A.; Fein, J. A.; Flynn, J. R.; Markovits, E.; Mayer, S.; Afuye, A. O.; Alperovich, A.; Anagnostou, T.; Besser, M. J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Cellular therapy during COVID-19: Lessons learned and preparing for subsequent waves
    Journal Article

    Nawas, M. T.; Shah, G. L.; Feldman, D. R.; Ruiz, J. D.; Robilotti, E. V.; Aslam, A. A.; Dundas, M.; Kamboj, M.; Barker, J. N.; Cho, C.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Immune reconstitution in the aging host: Opportunities for mechanism-based therapy in allogeneic hematopoietic cell transplantation
    Review

    Lin, R. J.; Elias, H. K.; van den Brink, M. R. M.
    Frontiers in Immunology (2021)

    Fulltext@MSK | Save
  • Implications of novel risks scores (AML-DRG and AML-HCT-CR) in allogeneic CD34+ selected graft transplant outcomes
    Meeting Abstract

    Trillo, R. A.; Recio, M. G.; Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • The impact of individual co-morbidities in myeloablative ex vivo CD34+ selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Shouval, R.; Fein, J. A.; Devlin, S. M.; Maloy, M. A.; Castillo Flores, N.; Lin, R. J.; Politikos, I.; Sanchez, M.; Scordo, M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save